STEPHANIE GREEN: Open Payments
NPI 1124528237 · SAINT MARYS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,194 in 63 payments from 17 companies in 2025. Trend: 2023 $1,012 · 2024 $944 · 2025 $1,194
Food & beverage: $1,194
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $147 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $128 |
| Astellas Pharma US Inc | 6 | $113 |
| Lilly USA, LLC | 5 | $105 |
| Novartis Pharmaceuticals Corporation | 4 | $104 |
| Amgen Inc. | 6 | $96 |
| Novo Nordisk Inc | 5 | $80 |
| Dexcom, Inc. | 4 | $62 |
| AstraZeneca Pharmaceuticals LP | 3 | $61 |
| GlaxoSmithKline, LLC. | 3 | $58 |
Products named: XIFAXAN, Veozah, MOUNJARO, LEQVIO, UBRELVY, Wegovy, OTEZLA, Dexcom G6 Transmitter.
Industry payments across GA — which companies pay providers there.
